Market

Praxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing.

Praxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing.
Shares of Praxis Precision Medicines have hit their highest intraday level since March 2022.
Read More

Related Posts

I tried to donate my crypto to charity. Here’s what I learned.

I tried to donate my crypto to charity. Here’s what I l...

Enanta Pharma chief product officer sells $30k in stock

Enanta Pharma chief product officer sells $30k in stock

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Form 6K Cementos Pacasmayo SAA ADR For: 5 December

Here’s how the best investors protect their money from market bubbles and FOMO

Here’s how the best investors protect their money from ...

Alphabet CEO Pichai Sundar sells $10.3m in GOOGL stock

Alphabet CEO Pichai Sundar sells $10.3m in GOOGL stock

SpaceX may be worth more than half of Tesla — with a sixth of the revenue

SpaceX may be worth more than half of Tesla — with a si...